TGFB1 and systemic sclerosis: In SSc, reduced expression of Cav‐1 enhances TGF‐β signaling, which subsequently further suppresses Cav‐1 levels at both the mRNA and protein levels, creating a feedback loop that amplifies fibrotic signaling and accelerates the progression of tissue fibrosis.